Lupin receives USFDA approval for antibiotic Solosec

The US Food and Drug Administration (USFDA) has approved the company#39;s sNDA to expand the use of Solosec in the treatment of bacterial vaginosis (BV) for female patients 12 years of age and older and in the treatment of trichomoniasis for all patients 12 years of age and above, Lupin Ltd said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/wu5lFjB